Nurami
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$652K
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of nanofiber sealant technology intended to focus on the soft tissue repair market. The company's technology is used to develop a unique substitute patch for neurosurgeries to prevent cerebrospinal fluid leakage and to regenerate the damaged dura, protecting the brain, enabling physicians to treat in an enhanced way.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
- P.O.B 1252
- Nazareth Illit
- Nazareth 1711102
- Israel
+972 00-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Nurami’s full profile, request a free trial.
Nurami Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 20-Dec-2016 | $652K | 00.000 | Completed | Startup | |
| 1. Seed Round | 01-Jan-2014 | 00000 | 00000 | Completed | Startup |
Nurami Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alfred Mann Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Israel Innovation Authority | Government | Minority | 000 0000 | 000000 0 | ||
| Next Generation Technology | Venture Capital | Minority | 000 0000 | 000000 0 |
Nurami Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Amir Bahar Ph.D | Co-Founder and Chief Executive Officer | ||
| Nora Nseir | Co-Founder & Chief Technology Officer |
Nurami Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Doron Birger | Self | Chairman | 000 0000 | |
| Zohar Gendler | Next Generation Technology | Board Member | 000 0000 |